Septerna, Inc. Appoints Rajiv Patni, M.D., as Chief Medical Officer

What Happened Septerna, Inc. announced in a Form 8-K filed August 25, 2026, that its Board of Directors appointed Rajiv Patni, M.D., as the Company’s Chief Medical Officer effective August 24, 2026. The company furnished a press release titled “Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer” as Exhibit 99.1 to the filing.

Key Details

• Appointment effective date: August 24, 2026.
• 8‑K filed: August 25, 2026 (Regulation FD Disclosure, Item 7.01; Other Events, Item 8.01).
• Press release furnished as Exhibit 99.1 to the Form 8‑K.

Why It Matters This is an executive leadership change: the Chief Medical Officer typically oversees clinical development, medical strategy and regulatory interactions—functions important to any clinical-stage or product-development company. For investors, the appointment signals Septerna is staffing its medical leadership, which may affect execution of clinical programs and communications about medical progress. The filing is informational and does not include financial changes or compensation details.